Behavioural Health Business Development Life Science Trials 
pharmaphorum
APRIL 25, 2022
Aaron Gani, founder and CEO of BehaVR, and Krys Zaluski, director of business development, digital health at Sumitomo Dainippon Pharma, discuss their groundbreaking partnership to develop and commercialise digital therapeutics (DTx) products. . Gani started BehaVR in 2016 to create DTx for mental and behavioural health.
pharmaphorum
JANUARY 26, 2021
From telehealth to digital trials, customer engagement to healthcare data, Healthware Group outlines the key trends that are expected to shake up digital health this year. Clinical trials get more and more digitalised. No more ‘business as usual’ for pharma’s customer engagement. Aging in place’ becomes more commonplace.
Expert insights. Personalized for you.
103 
Let's personalize your content